DE69929904D1 - Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen - Google Patents

Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen

Info

Publication number
DE69929904D1
DE69929904D1 DE69929904T DE69929904T DE69929904D1 DE 69929904 D1 DE69929904 D1 DE 69929904D1 DE 69929904 T DE69929904 T DE 69929904T DE 69929904 T DE69929904 T DE 69929904T DE 69929904 D1 DE69929904 D1 DE 69929904D1
Authority
DE
Germany
Prior art keywords
coated
controlled
size
particles
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929904T
Other languages
English (en)
Other versions
DE69929904T2 (de
Inventor
James D Talton
Guenther Hochhaus
Rajiv K Singh
James M Fitz-Gerald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of DE69929904D1 publication Critical patent/DE69929904D1/de
Publication of DE69929904T2 publication Critical patent/DE69929904T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/223—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating specially adapted for coating particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
    • C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
    • C23C14/24—Vacuum evaporation
    • C23C14/28—Vacuum evaporation by wave energy or particle radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
DE69929904T 1998-11-18 1999-11-18 Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen Expired - Lifetime DE69929904T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10884798P 1998-11-18 1998-11-18
US108847P 1998-11-18
US11029198P 1998-11-30 1998-11-30
US110291P 1998-11-30
PCT/US1999/027401 WO2000028969A2 (en) 1998-11-18 1999-11-18 Methods for preparing coated drug particles and pharmaceutical formulations thereof

Publications (2)

Publication Number Publication Date
DE69929904D1 true DE69929904D1 (de) 2006-04-20
DE69929904T2 DE69929904T2 (de) 2006-08-31

Family

ID=26806343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929904T Expired - Lifetime DE69929904T2 (de) 1998-11-18 1999-11-18 Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen

Country Status (19)

Country Link
EP (1) EP1131054B1 (de)
JP (1) JP2003516926A (de)
KR (1) KR20010082309A (de)
CN (1) CN1200693C (de)
AT (1) ATE317687T1 (de)
AU (1) AU757121B2 (de)
BR (1) BR9915462A (de)
CA (1) CA2350894C (de)
CZ (1) CZ300323B6 (de)
DE (1) DE69929904T2 (de)
ES (1) ES2257881T3 (de)
HK (1) HK1043548B (de)
HU (1) HUP0104687A3 (de)
IL (2) IL143234A0 (de)
NO (1) NO20012395L (de)
NZ (1) NZ511689A (de)
PL (1) PL349953A1 (de)
TR (1) TR200101401T2 (de)
WO (1) WO2000028969A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
EP1183018A1 (de) * 1999-06-07 2002-03-06 Nanosphere, Inc. Verfahren zum überziehen von teilchen und auf diese weise hergestellte teilchen
AU2005201757B2 (en) * 1999-06-07 2007-04-26 Nanotherapeutics, Inc. Methods for coating particles and particles produced thereby
US7217746B2 (en) 2000-05-19 2007-05-15 Ppg Industries Ohio, Inc. Coating compositions having a geometrically ordered array of polymeric particles and substrates coated therewith
ES2708961T3 (es) 2000-11-30 2019-04-12 Vectura Ltd Composiciones farmacéuticas para inhalación
DE60140268D1 (de) 2000-11-30 2009-12-03 Vectura Ltd Partikel zur verwendung in einer pharmazeutischen zusammensetzung
ATE361057T1 (de) * 2000-12-21 2007-05-15 Alrise Biosystems Gmbh Verfahren umfassend einen induzierten phasenübergang zur herstellung von hydrophobe wirkstoffe enthaltenden mikropartikeln
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
UA84276C2 (uk) * 2002-08-27 2008-10-10 Хіроші Терада Лікарський засіб проти туберкульозу
EP1479379B1 (de) 2003-05-19 2007-08-29 Euro-Celtique S.A. Trockene liposomale PVP-Jod Zubereitungen
EP1632225A4 (de) * 2003-06-11 2007-08-15 Nara Machinery Co Ltd Arzneimittel-nanoteilchen, verfahren und gerät zur herstellung einer pharmazeutischen zubereitung unter verwendung des teilchens
JP2006218346A (ja) * 2005-02-08 2006-08-24 Honda Motor Co Ltd 水素吸着材及びその製造方法
MX2009010479A (es) * 2007-03-30 2009-10-19 Otsuka Pharma Co Ltd Liposoma transpulmonar para controlar la llegada del farmaco.
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US20110014292A1 (en) * 2007-10-15 2011-01-20 Cooperative Research Centre For Asthma method of prophylaxis and agents for use therein
US20110111131A1 (en) * 2008-03-27 2011-05-12 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Method for producing a multicomponent, polymer- and metal-containing layer system, device and coated article
WO2009131537A1 (en) * 2008-04-25 2009-10-29 Karolinska Institutet Innovations Ab New therapy of treatment of the irritable bowel syndrome.
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
CN101888836A (zh) * 2008-10-15 2010-11-17 莱富凯尔创新私人有限公司 用于益康唑、莫西沙星和利福平的基于聚dl-丙交酯-共-乙交酯(plg)纳米粒子的口服药物递送系统
US20110223675A1 (en) * 2008-11-20 2011-09-15 Terumo Kabushiki Kaisha Drug release means from liposomes and method for evaluating releasability
SE535381C2 (sv) 2010-02-24 2012-07-17 Plasmadvance Ab Plasmasputtringsprocess för att producera partiklar
WO2013053793A1 (en) * 2011-10-14 2013-04-18 Dsm Ip Assets B.V. Novel coating system
JP6334214B2 (ja) * 2013-03-08 2018-05-30 学校法人慶應義塾 レーザーを用いた薬剤放出方法
CA3166756A1 (en) * 2020-02-19 2021-08-26 Nano Pharmasolutions, Inc. Therapeutic agent nanoparticles and methods of preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200669A (en) * 1978-11-22 1980-04-29 The United States Of America As Represented By The Secretary Of The Navy Laser spraying
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
DE3541999A1 (de) * 1985-11-28 1987-06-04 Bbc Brown Boveri & Cie Verfahren und vorrichtung zur beschichtung von flaechen
WO1990002546A1 (en) * 1988-09-09 1990-03-22 The Ronald T. Dodge Company Pharmaceuticals microencapsulated by vapor deposited polymers and method
DE4239244A1 (de) * 1992-11-21 1994-05-26 Basf Ag Retard-Form für pharmazeutische Wirkstoffe
US6025036A (en) * 1997-05-28 2000-02-15 The United States Of America As Represented By The Secretary Of The Navy Method of producing a film coating by matrix assisted pulsed laser deposition
WO1999047726A1 (en) * 1998-03-19 1999-09-23 The University Of Florida Process for depositing atomic to nanometer particle coatings on host particles

Also Published As

Publication number Publication date
CA2350894C (en) 2009-01-27
EP1131054B1 (de) 2006-02-15
JP2003516926A (ja) 2003-05-20
AU2345700A (en) 2000-06-05
NZ511689A (en) 2003-03-28
TR200101401T2 (tr) 2001-11-21
CN1200693C (zh) 2005-05-11
KR20010082309A (ko) 2001-08-29
PL349953A1 (en) 2002-10-21
HK1043548B (zh) 2006-01-06
CZ300323B6 (cs) 2009-04-22
IL143234A (en) 2007-05-15
HUP0104687A3 (en) 2006-07-28
IL143234A0 (en) 2002-04-21
NO20012395L (no) 2001-07-16
WO2000028969A3 (en) 2000-11-09
DE69929904T2 (de) 2006-08-31
HUP0104687A2 (en) 2002-06-29
CN1348361A (zh) 2002-05-08
AU757121B2 (en) 2003-02-06
BR9915462A (pt) 2001-12-11
HK1043548A1 (en) 2002-09-20
ATE317687T1 (de) 2006-03-15
ES2257881T3 (es) 2006-08-01
NO20012395D0 (no) 2001-05-15
CZ20011747A3 (cs) 2001-10-17
CA2350894A1 (en) 2000-05-25
WO2000028969A2 (en) 2000-05-25
EP1131054A2 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
DE69929904D1 (de) Methode zur herstellung von beschichteten partikeln und diese enthaltende pharmazeutische formulierungen
Mi et al. Reducing bacterial infections and biofilm formation using nanoparticles and nanostructured antibacterial surfaces
Liu et al. Electrospun PVP-core/PHBV-shell fibers to eliminate tailing off for an improved sustained release of curcumin
Losic et al. Titania nanotube arrays for local drug delivery: recent advances and perspectives
Gulati et al. Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays
DE69121675T2 (de) Mikrosphäre enthaltende pharmazeutische Zusammensetzung mit kontrollierter Freigabe und Verfahren zur Herstellung
Rana et al. Surface functionalization of nanobiomaterials for application in stem cell culture, tissue engineering, and regenerative medicine
Zuidema et al. Oriented nanofibrous polymer scaffolds containing protein‐loaded porous silicon generated by spray nebulization
BRPI0410956A (pt) pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
Hadjiargyrou et al. Enhanced composite electrospun nanofiber scaffolds for use in drug delivery
FR09C0050I2 (fr) Agents pharmaceutiquement actifs stabilises par proteine et leur utilisation
DE59104172D1 (de) Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren.
WO2001091725A3 (en) Biologically useful polyphosphates
Tseng et al. Nanofibers used for the delivery of analgesics
CN107308136A (zh) 一种载抗肿瘤药物电纺微米纤维膜及其制备方法
Lee et al. Integrating cold atmospheric plasma with 3D printed bioactive nanocomposite scaffold for cartilage regeneration
US20170100521A1 (en) Patterned surfaces
EA200702518A1 (ru) Композиции на основе наночастиц и с контролируемым высвобождением, включающие цефалоспорин
Aljohani et al. One-pot microwave synthesis of chitosan-stabilized silver nanoparticles entrapped polyethylene oxide nanofibers, with their intrinsic antibacterial and antioxidant potency for wound healing
Nasiri et al. 3D printing of bioactive materials for drug delivery applications
Slepička et al. Enhancement of polymer cytocompatibility by nanostructuring of polymer surface
Yoha et al. Surface modification of bio-polymeric nanoparticles and its applications
RU2001135712A (ru) Способ нанесения покрытий на частицы и частицы, полученые этим способом
Verma et al. Surface Modification of Biodegradable Polymers
Swarupa et al. Techniques, applications and prospects of polysaccharide and protein based biopolymer coatings: A review

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: TALTON, D., JAMES, GAINESVILLE, FL 32605, US

Inventor name: HOCHHAUS, GUENTHER, GAINESVILLE, FL 32608, US

Inventor name: SINGH, K., RAJIV, GAINESVILLE, FL 32607, US

Inventor name: FITZ-GERALD, JAMES M., NAVY RESEARCH LABORATORY, W

8364 No opposition during term of opposition